| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CHINOOK THERAPEUTICS, INC. | 10%+ Owner | Common Stock | 2,913,070 | $113,694,209 | $39.03 | 04 Apr 2022 | Direct |
| LENZ Therapeutics, Inc. | 10%+ Owner | Common Stock | 1,598,789 | $6,523,059 | $4.08 | 21 Mar 2024 | Direct |
| CHINOOK THERAPEUTICS, INC. | 10%+ Owner | Common Stock | 0 | $39.03 | 04 Apr 2022 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LENZ | LENZ Therapeutics, Inc. | 21 Mar 2024 | 0 | $0 | 3 | 10%+ Owner | 25 Mar 2024, 16:19 |
| /report/000089924322014108-versant-venture-capital-vii-l-p-2022-04-04 | CHINOOK THERAPEUTICS, INC. | 04 Apr 2022 | 5 | $0 | 4 | 10%+ Owner | 06 Apr 2022, 16:38 |
| /report/000089924322000946-versant-venture-capital-vii-l-p-2022-01-03 | CHINOOK THERAPEUTICS, INC. | 03 Jan 2022 | 3 | -$16,000,200 | 4 | 10%+ Owner | 05 Jan 2022, 16:16 |
| /report/000089924321034627-versant-venture-capital-vii-l-p-2021-08-27 | CHINOOK THERAPEUTICS, INC. | 27 Aug 2021 | 3 | -$11,900,000 | 4 | 10%+ Owner | 31 Aug 2021, 19:06 |